We are live on ! Find out more
AVM

Avalon Ventures Management Portfolio holdings

AUM $14.2M
1-Year Est. Return 9.35%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+9.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19M
AUM Growth
+$2.17M
Cap. Flow
+$1.14M
Cap. Flow %
6%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
JANX icon
Janux Therapeutics
JANX
+$1.14M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 94.74%
2 Healthcare 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLTR icon
1
Kaltura
KLTR
$206M
$18M 94.74%
8,962,707
JANX icon
2
Janux Therapeutics
JANX
$925M
$1M 5.26%
+43,300
New +$1.14M

Similar funds

Avalon Ventures Management's Q2 2025 Portfolio in Review

As of Q2 2025, Avalon Ventures Management held 2 positions worth $19M, up 13% from $16.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Avalon Ventures Management deployed $1.14M of net new capital in Q2 2025, opening 1 new position. Its largest new stake was Janux Therapeutics: 43,300 shares worth $1M.

By sector, the portfolio is most concentrated in Technology at 95% of assets, down from 100% a quarter earlier, followed by Healthcare.

  • Avalon Ventures Management's largest Q2 2025 buy was Janux Therapeutics: 43,300 shares worth $1M.
  • Avalon Ventures Management's ten largest holdings make up 100% of its $19M portfolio in Q2 2025.
  • Avalon Ventures Management opened 1 new position and closed 0 in Q2 2025.
  • Avalon Ventures Management's portfolio value rose 13% quarter-over-quarter to $19M.

Based on Avalon Ventures Management's 13F filing for Q2 2025, filed 25 Jul 2025.